122020-56-8

Basic information

• Product Name: 4-Butyl-N-((Z)-octadec-9-enyl)-benzamide
• CAS NO: 122020-56-8
• Molecular Weight: 427.714
• Mol File: 122020-56-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-Butyl-N-((Z)-octadec-9-enyl)-benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Butyl-N-((Z)-octadec-9-enyl)-benzamide(122020-56-8)
• EPA Substance Registry System: 4-Butyl-N-((Z)-octadec-9-enyl)-benzamide(122020-56-8)

Safety Data

• Hazardous Substances Data: 122020-56-8(Hazardous Substances Data)

Upstream product

• 20651-71-2 4-butyl benzoic acid 
• 112-90-3 (Z)-9-octadecen-1-amine 
• 28788-62-7 4-butylbenzoyl chloride 

Downstream Products

• 122020-49-9 1-(4-Butyl-benzyl)-3-(2,4-dimethyl-phenyl)-1-((Z)-octadec-9-enyl)-urea 
• 122020-61-5 (4-Butyl-benzyl)-((Z)-octadec-9-enyl)-amine 

Relevant articles and documents

Potential Antiatherosclerotic Agents. 6. Hypocholesterolemic Trisubstituted Urea Analogues

The discovery that a series of N,N-dialkyl-N'-arylureas were inhibitors of the ACAT enzyme has led to a structure-activity study involving the systematic modification of three sites of the urea backbone.This study culminated in the selection of N'-(2,4-dimethylphenyl)-N-benzyl-N-n-butylurea (115) for more extensive biological evaluation.ACAT inhibitors are seen as potentially beneficial agents against hypercholesterolemia and atherosclerosis.